Abstract:BACKGROUND:It has been reported that osteopontin has an important role in cardiac fibrosis and remodeling. However, its direct mechanisms remain unclear. The purpose of this study was to investigate the role of angiotensin and aldosterone blockades in cardiac osteopontin expression associated with cardiac remodeling in myocardial infarcted (MI) rats.METHODS:Fifty SD rats that survived 24 hours after ligating left anterior descending coronary artery were randomly divided into three groups: MI-saline group (n = 15, 5 ml/d), MI-perindopril group (n = 18, perindopril 2 mgxkg(-1)d(-1)) and MI-spironolacton (n = 17, spironolacton 20 mgxkg(-1)xd(-1)). A sham operation group (n = 15) was selected as non-infarcted control. At 6 weeks after treatment, hemodynamic pararmeters and left ventricular function were measured with catheterization, interstitial fibrosis infiltration and cardiomyocyte diameters were evaluated histologically. Myocardium osteopontin protein expression level in the non-infarcted myocardium was detected by Western blotting.RESULTS:No osteopontin protein was detected in the myocardium of sham-operation rats. High levels of osteopontin protein expression were detected in the MI-saline rats, but the levels were suppressed in the MI-perindopril and MI-spironolacton rats at 6 weeks following MI (P < 0.01, respectively). Compared with the sham operation group, all rats in the MI group showed marked interstitial fibrosis infiltration in the non-infarction area, higher ventricular weight/body weight ratio, significantly increased cardiomyocyte diameter (P < 0.01, respectively), and developed significant systolic and diastolic dysfunction as indicated by decreased left ventricular systolic pressure (LVSP) and +/-dp/dt, as well as increased left ventricular end-diastolic pressure (LVEDP) (P < 0.01, respectively). Angiotensin and aldosterone blockades partly prevented cardiac fibrosis and systolic and diastolic dysfunction (P < 0.01, respectively).CONCLUSION:Treatment with angiotensin and aldosterone blockades inhibits expression of osteopontin in the non-infarcted myocardium and prevents cardiac remodeling following MI.

Aldosterone-induced Osteopontin Expression in Vascular Smooth Muscle Cells Involves MR, ERK, and P38 MAPK

Osteopontin Regulates the Proliferation of Rat Aortic Smooth Muscle Cells in Response to Gingipains Treatment

Ang Ⅱ-induced Migration of Vascular Smooth Muscle Cells Involves Osteopontin

Increased expression of osteoprotegerin in vascular smooth muscle cells from spontaneously hypertensive rats

Expression And Function Of Osteopontin In Vascular Adventitial Fibroblasts And Pathological Vascular Remodeling

Adrenomedullin up-regulates osteopontin and attenuates vascular calcification via the cAMP/PKA signaling pathway

Endogenous aldosterone is involved in vascular calcification in rat.

Aldosterone promotes calcification of vascular smooth muscle cells in mice through the AIF-1/Wnt/β-catenin signaling pathway

Activation of Src-ATF1 pathway is involved in upregulation of Nox1, a catalytic subunit of NADPH oxidase, by aldosterone.

Homocysteine Induces the Expression of C-reactive Protein Via NMDAr-ROS-MAPK-NF-κB Signal Pathway in Rat Vascular Smooth Muscle Cells

The Role and Possible Mechanism of Aldosterone in the Vascular Calcification of Rats

[Effects of Aldosterone on Osteoblast Proliferation, Differentiation and Osteogenic Gene Expressions in Vitro].

Osteopontin Activates Retinal Microglia Causing Retinal Ganglion Cells Loss Via P38 MAPK Signaling Pathway in Glaucoma.

Role of Osteopontin in Angiotensin Ii-Induced Cardiac Fibrosis and Remodeling

Osteopontin induces vascular endothelial growth factor expression in articular cartilage through PI3K/AKT and ERK1/2 signaling

Role of Osteopontin in Cardiac Fibrosis and Remodeling in Angiotensin Ii - Induced Cardiac Hypertrophy

Blockades of Angiotensin and Aldosterone Reduce Osteopontin Expression and Interstitial Fibrosis Infiltration in Rats with Myocardial Infarction.

Aldosterone is a Possible New Stimulating Factor for Promoting Vascular Calcification.

Aldosterone activates ERK1/2 and p38map kinase in vascular smooth muscle cells by nongenomic mechanisms in WKY and SHR – role of endothelin-1

Aldosterone Enhances High Phosphate-Induced Vascular Calcification Through Inhibition Of Ampk-Mediated Autophagy

Mineralocorticoid receptor antagonism protects the aorta from vascular smooth muscle cell proliferation and collagen deposition in a rat model of adrenal aldosterone-producing adenoma